Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-22 4:56 PM View:  | Aclaris Therapeutics, Inc. (ACRS) | 10-Mar-22 | Private Sale | 12,823 | $15.55 | $199,335.00 | (6%) 214.71K to 201.88K | |
| 03-Mar-22 6:08 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-22 | Option Exercise | 8,297 | -- | -- | 4% 206.41K to 214.71K | |
| 03-Mar-22 6:08 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Mar-22 | Option Exercise | 34,050 | -- | -- | 20% 172.36K to 206.41K | |
| 11-Feb-22 10:00 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 09-Feb-22 | Market Sale | 1,388 | $12.66 | $17,568.50 | (< 1%) 173.75K to 172.36K | 2% |
| 03-Feb-22 4:46 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-22 | Option Exercise | 3,875 | -- | -- | 2% 169.87K to 173.75K | |
| 02-Jun-21 9:43 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Jun-21 | Market Option Sale | 15,037 | $21.64 | $325,383.00 | (8%) 184.91K to 169.87K | |
| 02-Jun-21 9:43 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jun-21 | Option Exercise | 33,189 | -- | -- | 22% 151.72K to 184.91K | |
| 26-Apr-21 9:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 26-Apr-21 | Market Sale (Planned) | 27,339 | $25.80 | $705,228.00 | (15%) 179.06K to 151.72K | (4%) |
| 26-Apr-21 9:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 23-Apr-21 | Market Sale (Planned) | 30,000 | $26.66 | $799,660.00 | (14%) 209.06K to 179.06K | (< 1%) |
| 26-Apr-21 9:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 22-Apr-21 | Market Sale (Planned) | 30,000 | $26.84 | $805,218.00 | (13%) 239.06K to 209.06K | < 1% |
| 03-Mar-21 8:36 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-21 | Payment of Exercise | 2,844 | $23.25 | $66,123.00 | (1%) 241.9K to 239.06K | |
| 03-Mar-21 8:36 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-21 | Option Exercise | 8,297 | -- | -- | 4% 233.61K to 241.9K | |
| 03-Mar-21 8:36 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Mar-21 | Payment of Exercise | 7,333 | $24.06 | $176,432.00 | (3%) 240.94K to 233.61K | |
| 03-Mar-21 8:36 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Mar-21 | Option Exercise | 25,750 | -- | -- | 12% 215.19K to 240.94K | |
| 03-Feb-21 5:29 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-21 | Payment of Exercise | 1,308 | $21.35 | $27,925.80 | (< 1%) 216.5K to 215.19K | |
| 03-Feb-21 5:29 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-21 | Option Exercise | 3,875 | -- | -- | 2% 212.62K to 216.5K | |
| 17-Dec-20 5:07 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Dec-20 | Payment of Exercise | 370 | $4.59 | $1,698.30 | (< 1%) 212.99K to 212.62K | (53%) |
| 17-Dec-20 5:07 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Dec-20 | Option Exercise | 1,300 | -- | -- | < 1% 211.69K to 212.99K | |
| 03-Jun-20 4:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jun-20 | Payment of Exercise | 9,451 | $1.32 | $12,475.30 | (4%) 221.14K to 211.69K | (432%) |
| 03-Jun-20 4:45 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jun-20 | Option Exercise | 33,188 | -- | -- | 18% 187.96K to 221.14K | |
| 04-Mar-20 4:30 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-20 | Payment of Exercise | 7,162 | $1.26 | $9,024.12 | (4%) 195.12K to 187.96K | (453%) |
| 04-Mar-20 4:30 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-20 | Option Exercise | 25,750 | -- | -- | 15% 169.37K to 195.12K | |
| 04-Feb-20 7:12 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Feb-20 | Payment of Exercise | 1,308 | $1.28 | $1,674.24 | (< 1%) 170.68K to 169.37K | (445%) |
| 04-Feb-20 7:12 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Feb-20 | Option Exercise | 3,875 | -- | -- | 2% 166.8K to 170.68K | |
| 20-Dec-19 4:18 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-19 | Payment of Exercise | 356 | $1.81 | $644.36 | (< 1%) 167.16K to 166.8K | (285%) |
| 20-Dec-19 4:18 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-19 | Option Exercise | 1,250 | -- | -- | < 1% 165.91K to 167.16K | |
| 18-Dec-19 11:02 AM View: | Aclaris Therapeutics, Inc. (ACRS) | 16-Dec-19 | Payment of Exercise | 370 | $1.80 | $666.00 | (< 1%) 166.28K to 165.91K | (287%) |
| 18-Dec-19 11:02 AM View: | Aclaris Therapeutics, Inc. (ACRS) | 16-Dec-19 | Option Exercise | 1,300 | -- | -- | < 1% 164.98K to 166.28K | |
| 05-Feb-19 6:31 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-19 | Payment of Exercise | 1,308 | $6.96 | $9,103.68 | (< 1%) 166.28K to 164.98K | < 1% |
| 05-Feb-19 6:31 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Feb-19 | Option Exercise | 3,875 | -- | -- | 2% 162.41K to 166.28K | |
| 21-Dec-18 7:34 AM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-18 | Payment of Exercise | 356 | $6.30 | $2,242.80 | (< 1%) 162.76K to 162.41K | (10%) |
| 21-Dec-18 7:34 AM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-18 | Option Exercise | 1,250 | -- | -- | < 1% 161.51K to 162.76K | |
| 18-Dec-18 8:54 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Dec-18 | Payment of Exercise | 370 | $7.31 | $2,704.70 | (< 1%) 161.88K to 161.51K | 5% |
| 18-Dec-18 8:54 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Dec-18 | Option Exercise | 1,300 | -- | -- | < 1% 160.59K to 161.88K | |
| 09-May-18 4:20 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 07-May-18 | Payment of Exercise | 1,480 | $18.10 | $26,788.00 | (< 1%) 162.06K to 160.59K | 62% |
| 09-May-18 4:20 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 07-May-18 | Option Exercise | 5,200 | -- | -- | 3% 156.87K to 162.06K | |
| 07-May-18 4:28 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 07-May-18 | Market Purchase (Planned) | 1,250 | $18.22 | $22,775.00 | < 1% 155.62K to 156.87K | (62%) |
| 09-Apr-18 4:51 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 06-Apr-18 | Market Purchase (Planned) | 1,250 | $16.59 | $20,737.50 | < 1% 154.37K to 155.62K | (58%) |
| 20-Mar-18 5:00 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 16-Mar-18 | Acquisition (other) | 9,018 | -- | -- | 6% 145.35K to 154.37K | |
| 21-Dec-17 4:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-17 | Payment of Exercise | 380 | $24.12 | $9,165.60 | (< 1%) 145.73K to 145.35K | 71% |
| 21-Dec-17 4:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-17 | Option Exercise | 1,250 | -- | -- | < 1% 144.48K to 145.73K | |
| 21-Dec-17 4:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Dec-17 | Payment of Exercise | 395 | $24.23 | $9,570.85 | (< 1%) 144.87K to 144.48K | 71% |
| 21-Dec-17 4:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Dec-17 | Option Exercise | 1,300 | -- | -- | < 1% 143.57K to 144.87K | |
| 20-Dec-16 6:51 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-16 | Payment of Exercise | 380 | $31.25 | $11,875.00 | (< 1%) 143.95K to 143.57K | 78% |
| 20-Dec-16 6:51 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Dec-16 | Option Exercise | 1,250 | -- | -- | < 1% 142.7K to 143.95K | |
| 19-Sep-16 7:07 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 15-Sep-16 | Acquisition (other) | 4,790 | -- | -- | 3% 137.91K to 142.7K | |
| 13-Oct-15 1:23 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 13-Oct-15 | Conversion | 7,478 | -- | -- | 6% 130.43K to 137.91K |